A phase II study of sitravatinib (Sitra) in combination with nivolumab (Nivo) in patients (Pts) undergoing nephrectomy for locally-advanced clear cell renal cell carcinoma (accRCC). Health-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results